Form 8-K - Current report:
SEC Accession No. 0001193125-22-127526
Filing Date
2022-04-28
Accepted
2022-04-28 16:05:48
Documents
13
Period of Report
2022-04-28
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d329281d8k.htm   iXBRL 8-K 29226
2 EX-10.1 d329281dex101.htm EX-10.1 748997
  Complete submission text file 0001193125-22-127526.txt   1057244

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA cme-20220428.xsd EX-101.SCH 2858
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE cme-20220428_lab.xml EX-101.LAB 17237
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cme-20220428_pre.xml EX-101.PRE 10815
7 EXTRACTED XBRL INSTANCE DOCUMENT d329281d8k_htm.xml XML 3203
Mailing Address 20 S. WACKER DR. CHICAGO IL 60606
Business Address 20 S. WACKER DR. CHICAGO IL 60606 3129301000
CME GROUP INC. (Filer) CIK: 0001156375 (see all company filings)

EIN.: 364459170 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-31553 | Film No.: 22866471
SIC: 6200 Security & Commodity Brokers, Dealers, Exchanges & Services